Here We Go Again: US FDA Weighing Accelerated Approval For Biogen’s ALS Drug Tofersen

 
• By Sue Sutter
  
Opening the door
Tofersen could open the door to use of the accelerated approval pathway for other ALS treatments. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Approval Standards

More from Pathways & Standards